Mon, July 17, 2023
Fri, July 14, 2023
Thu, July 13, 2023
Wed, July 12, 2023

Matthew Sykes Maintained (TWST) at Hold with Increased Target to $20 on, Jul 13th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-20-on-jul-13th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Increased Target from $18 to $20 on, Jul 13th, 2023.

Matthew has made no other calls on TWST in the last 4 months.



There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Catherine Ramsey of "Baird" Maintained at Buy with Decreased Target to $18 on, Monday, May 8th, 2023
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $20 on, Monday, May 8th, 2023

Publication Contributing Sources